{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:20:51Z","timestamp":1788898851673,"version":"build-2803163510"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["QGZ-2018094"],"award-info":[{"award-number":["QGZ-2018094"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171015"],"award-info":[{"award-number":["32171015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajp.2025.104502","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T02:31:01Z","timestamp":1745029861000},"page":"104502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists"],"prefix":"10.1016","volume":"108","author":[{"given":"Mingrui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6408-895X","authenticated-orcid":false,"given":"Xiaobai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.ajp.2025.104502_bib1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1523\/JNEUROSCI.5531-08.2009","article-title":"NMDA receptor GluN2B (GluR epsilon 2\/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses","volume":"29","author":"Akashi","year":"2009","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.ajp.2025.104502_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40263-023-01032-5","article-title":"Dextromethorphan-bupropion for the treatment of depression: a systematic review of efficacy and safety in clinical trials","volume":"37","author":"Akbar","year":"2023","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-013-3153-2","article-title":"Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR","volume":"230","author":"Akinfiresoye","year":"2013","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"12","key":"10.1016\/j.ajp.2025.104502_bib4","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1523\/JNEUROSCI.2970-04.2005","article-title":"Early presynaptic and late postsynaptic components contribute independently to brain-derived neurotrophic factor-induced synaptic plasticity","volume":"25","author":"Alder","year":"2005","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.10.057","article-title":"Involvement of PKA, MAPK\/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice","volume":"395","author":"Almeida","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ajp.2025.104502_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jcpt.12469","article-title":"Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study","volume":"42","author":"Amidfar","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ajp.2025.104502_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainresbull.2016.11.003","article-title":"Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain","volume":"128","author":"Amidfar","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ajp.2025.104502_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2018.03.023","article-title":"The role of memantine in the treatment of major depressive disorder: clinical efficacy and mechanisms of action","volume":"827","author":"Amidfar","year":"2018","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.pharep.2017.12.007","article-title":"Effectiveness of memantine on depression-like behavior, memory deficits and brain mRNA levels of BDNF and TrkB in rats subjected to repeated unpredictable stress","volume":"70","author":"Amidfar","year":"2018","journal-title":"Pharm. Rep."},{"issue":"7354","key":"10.1016\/j.ajp.2025.104502_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.ajp.2025.104502_bib13","doi-asserted-by":"crossref","first-page":"5093048","DOI":"10.1155\/2018\/5093048","article-title":"NMDA receptor subunits change after synaptic plasticity induction and learning and memory acquisition","volume":"2018","author":"Baez","year":"2018","journal-title":"Neural Plast."},{"issue":"9","key":"10.1016\/j.ajp.2025.104502_bib14","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.ajp.2025.104502_bib15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/00048670802512073","article-title":"Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression","volume":"42","author":"Bennett","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.ajp.2025.104502_bib18","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"26","author":"Bonaventura","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mcn.2007.02.019","article-title":"BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons","volume":"35","author":"Caldeira","year":"2007","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.ajp.2025.104502_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.ajp.2025.104502_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106837","article-title":"Molecular mechanisms of rapid-acting antidepressants: new perspectives for developing antidepressants","volume":"194","author":"Chen","year":"2023","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00109-020-01982-z","article-title":"Memantine in neurological disorders - schizophrenia and depression","volume":"99","author":"Czarnecka","year":"2021","journal-title":"J. Mol. Med (Berl. )"},{"issue":"8","key":"10.1016\/j.ajp.2025.104502_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","article-title":"The AMPA receptor code of synaptic plasticity","volume":"100","author":"Diering","year":"2018","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger. 1965","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S1461145704004432","article-title":"Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders","volume":"7","author":"Du","year":"2004","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.ajp.2025.104502_bib28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0006-3223(00)00935-5","article-title":"Neuronal plasticity and survival in mood disorders","volume":"48","author":"Duman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","article-title":"Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections","volume":"16","author":"Duman","year":"2014","journal-title":"Dialog-. Clin. Neurosci."},{"issue":"6103","key":"10.1016\/j.ajp.2025.104502_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ajp.2025.104502_bib31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR\u2082\/\u2083 blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.ajp.2025.104502_bib33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNF.0b013e3180314ae7","article-title":"An open-label, flexible-dose study of memantine in major depressive disorder","volume":"30","author":"Ferguson","year":"2007","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1523\/JNEUROSCI.16-01-00274.1996","article-title":"Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents","volume":"16","author":"Fitzgerald","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ajp.2025.104502_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109476","article-title":"A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice","volume":"342","author":"Fraga","year":"2021","journal-title":"Chem. Biol. Inter."},{"issue":"8","key":"10.1016\/j.ajp.2025.104502_bib37","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s11011-021-00743-2","article-title":"Ketamine, but not fluoxetine, rapidly rescues corticosterone-induced impairments on glucocorticoid receptor and dendritic branching in the hippocampus of mice","volume":"36","author":"Fraga","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant Potential of (R)-Ketamine in Rodent Models: comparison with (S)-Ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0269881118760660","article-title":"Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial","volume":"32","author":"G\u00e1lvez","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2025.104502_bib41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1742-7843.2008.00210.x","article-title":"Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels","volume":"103","author":"Garcia","year":"2008","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.ajp.2025.104502_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172856","article-title":"Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation","volume":"189","author":"Gilbert","year":"2020","journal-title":"Pharm. Biochem Behav."},{"issue":"19","key":"10.1016\/j.ajp.2025.104502_bib43","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/hmg\/ddg267","article-title":"Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice","volume":"12","author":"Guo","year":"2003","journal-title":"Hum. Mol. Genet"},{"issue":"10","key":"10.1016\/j.ajp.2025.104502_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.ajp.2025.104502_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.ajp.2025.104502_bib46","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14728222.2016.1238899","article-title":"Ketamine's antidepressant action: beyond NMDA receptor inhibition","volume":"20","author":"Hashimoto","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00406-016-0692-7","article-title":"Reduction of dopamine D(2\/3) receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys","volume":"267","author":"Hashimoto","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2025.104502_bib48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-physiol-021014-071753","article-title":"Long-term potentiation: from CaMKII to AMPA receptor trafficking","volume":"78","author":"Herring","year":"2016","journal-title":"Annu Rev. Physiol."},{"key":"10.1016\/j.ajp.2025.104502_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114892","article-title":"Mechanisms of ketamine and its metabolites as antidepressants","volume":"197","author":"Hess","year":"2022","journal-title":"Biochem Pharm."},{"issue":"10","key":"10.1016\/j.ajp.2025.104502_bib50","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41386-019-0380-1","article-title":"Group II metabotropic glutamate receptor blockade promotes stress resilience in mice","volume":"44","author":"Highland","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ajp.2025.104502_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109171","article-title":"Ketamine; history and role in anesthetic pharmacology","volume":"216","author":"Hirota","year":"2022","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","article-title":"Antidepressants and hypothalamic-pituitary-adrenocortical regulation","volume":"17","author":"Holsboer","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ajp.2025.104502_bib53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jad.2022.03.047","article-title":"The efficacy and tolerability of memantine for depressive symptoms in major mental diseases: a systematic review and updated meta-analysis of double-blind randomized controlled trials","volume":"306","author":"Hsu","year":"2022","journal-title":"J. Affect Disord."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12640-012-9348-1","article-title":"Neuroinflammation, neurodegeneration, and depression","volume":"23","author":"Hurley","year":"2013","journal-title":"Neurotox. Res"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/02698811241303597","article-title":"Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature","volume":"39","author":"Ingrosso","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib56","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14345","article-title":"Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in patients with major depressive disorder: a phase 3 randomized clinical trial (GEMINI)","volume":"83","author":"Iosifescu","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib57","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.mp.4000712","article-title":"Adult brain neurogenesis and psychiatry: a novel theory of depression","volume":"5","author":"Jacobs","year":"2000","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12955-023-02113-1","article-title":"Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant","volume":"21","author":"Jamieson","year":"2023","journal-title":"Health Qual. Life Outcomes"},{"issue":"12","key":"10.1016\/j.ajp.2025.104502_bib59","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00213-023-06454-z","article-title":"MK-801 and cognitive functions: investigating the behavioral effects of a non-competitive NMDA receptor antagonist","volume":"240","author":"Janus","year":"2023","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"102","key":"10.1016\/j.ajp.2025.104502_bib60","doi-asserted-by":"crossref","first-page":"102mr2","DOI":"10.1126\/scitranslmed.3002804","article-title":"Translating glutamate: from pathophysiology to treatment","volume":"3","author":"Javitt","year":"2011","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib61","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.23m14974","article-title":"A randomized, double-blind, placebo-controlled pilot trial of the acute antisuicidal and antidepressant effects of intranasal (R,S)-ketamine in severe unipolar and bipolar depression with and without comorbid alcohol use disorder","volume":"85","author":"Jones","year":"2024","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104502_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainresbull.2020.07.022","article-title":"Rapid acting antidepressants in the mTOR pathway: current evidence","volume":"163","author":"K","year":"2020","journal-title":"Brain Res Bull."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S1461145708008985","article-title":"Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression","volume":"12","author":"Karolewicz","year":"2009","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.ajp.2025.104502_bib65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","article-title":"Ketamine: a paradigm shift for depression research and treatment","volume":"101","author":"Krystal","year":"2019","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cell.2020.02.033","article-title":"A new rapid-acting antidepressant","volume":"181","author":"Krystal","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ajp.2025.104502_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104171","article-title":"A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression","volume":"99","author":"Kumar","year":"2024","journal-title":"Asian J. Psychiatr."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.ajp.2025.104502_bib70","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpsychires.2010.01.005","article-title":"Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment","volume":"44","author":"Larsen","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib71","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflug. Arch."},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib72","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00406-020-01110-5","article-title":"Intravenous arketamine for treatment-resistant depression: open-label pilot study","volume":"271","author":"Leal","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5994","key":"10.1016\/j.ajp.2025.104502_bib73","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ajp.2025.104502_bib74","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fpsyt.2018.00767","article-title":"Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: evidence from clinical neuroimaging studies","volume":"9","author":"Li","year":"2018","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.ajp.2025.104502_bib76","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2174\/138161209788168010","article-title":"Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders","volume":"15","author":"Machado-Vieira","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0306-4522(95)00259-L","article-title":"Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors","volume":"69","author":"Magari\u00f1os","year":"1995","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD: an embarrassment of riches","volume":"44","author":"Malenka","year":"2004","journal-title":"Neuron"},{"issue":"10161","key":"10.1016\/j.ajp.2025.104502_bib79","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2025.104502_bib80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pnpbp.2012.12.012","article-title":"Synaptic plasticity in depression: molecular, cellular and functional correlates","volume":"43","author":"Marsden","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/mcne.2001.1027","article-title":"The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain","volume":"18","author":"Marvanov\u00e1","year":"2001","journal-title":"Mol. Cell Neurosci."},{"issue":"5","key":"10.1016\/j.ajp.2025.104502_bib82","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.mehy.2012.02.009","article-title":"Glutamate-based depression GBD","volume":"78","author":"McCarthy","year":"2012","journal-title":"Med Hypotheses"},{"issue":"5","key":"10.1016\/j.ajp.2025.104502_bib83","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.ajp.2025.104502_bib84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(94)91622-5","article-title":"Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate","volume":"655","author":"Moghaddam","year":"1994","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.ajp.2025.104502_bib85","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib86","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuint.2012.01.004","article-title":"Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators","volume":"61","author":"Monaghan","year":"2012","journal-title":"Neurochem. Int"},{"issue":"6","key":"10.1016\/j.ajp.2025.104502_bib87","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential antidepressive properties of amantadine, memantine and bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharm. Toxicol."},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib88","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4088\/JCP.v69n0308","article-title":"Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence","volume":"69","author":"Muhonen","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib89","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104502_bib90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"J. Affect Disord."},{"issue":"6","key":"10.1016\/j.ajp.2025.104502_bib91","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14740338.2022.2066651","article-title":"Long-term safety of ketamine and esketamine in treatment of depression","volume":"21","author":"Nikayin","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"issue":"16","key":"10.1016\/j.ajp.2025.104502_bib92","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1523\/JNEUROSCI.4998-12.2013","article-title":"Acute suppression of spontaneous neurotransmission drives synaptic potentiation","volume":"33","author":"Nosyreva","year":"2013","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.ajp.2025.104502_bib93","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.biopsych.2018.09.026","article-title":"The role of dendritic brain-derived neurotrophic factor transcripts on altered inhibitory circuitry in depression","volume":"85","author":"Oh","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104502_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110239","article-title":"The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL\/6J mice","volume":"109","author":"Pa\u0142ucha-Poniewiera","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104502_bib95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neubiorev.2019.04.010","article-title":"Stress, epigenetics and depression: a systematic review","volume":"102","author":"Park","year":"2019","journal-title":"Neurosci. Biobehav Rev."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib96","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ajp.2025.104502_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104159","article-title":"Treatment-emergent symptoms during short-term ketamine administration in treatment-resistant bipolar depression: a retrospective cross-sectional descriptive study","volume":"99","author":"Pastuszak","year":"2024","journal-title":"Asian J. Psychiatr."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3565(25)38715-X","article-title":"Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments","volume":"269","author":"Paul","year":"1994","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.ajp.2025.104502_bib99","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/537265","article-title":"Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication","volume":"2013","author":"Pilar-Cu\u00e9llar","year":"2013","journal-title":"Neural Plast."},{"issue":"10","key":"10.1016\/j.ajp.2025.104502_bib100","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/17460441.2022.2111415","article-title":"Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2\/3 receptor antagonism","volume":"17","author":"Pilc","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib101","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib102","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152707780363267","article-title":"The NMDA receptor as a therapeutic target in major depressive disorder","volume":"6","author":"Pittenger","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib103","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1034\/j.1399-5618.2002.01159.x","article-title":"Modulation of synaptic plasticity by stress and antidepressants","volume":"4","author":"Popoli","year":"2002","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib104","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1042\/BST20140323","article-title":"Regulation and roles of elongation factor 2 kinase","volume":"43","author":"Proud","year":"2015","journal-title":"Biochem Soc. Trans."},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00406-020-01208-w","article-title":"Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling","volume":"271","author":"Qu","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2025.104502_bib106","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2011.03.026","article-title":"Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model","volume":"182","author":"Quan","year":"2011","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.ajp.2025.104502_bib107","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuron.2018.05.018","article-title":"Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert","volume":"98","author":"Reiner","year":"2018","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.ajp.2025.104502_bib108","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.brainresbull.2009.11.013","article-title":"Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression?","volume":"81","author":"R\u00e9us","year":"2010","journal-title":"Brain Res Bull."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib109","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11011-012-9281-2","article-title":"Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats","volume":"27","author":"R\u00e9us","year":"2012","journal-title":"Metab. Brain Dis."},{"issue":"8","key":"10.1016\/j.ajp.2025.104502_bib110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3z","year":"2002","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.ajp.2025.104502_bib111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.ajp.2025.104502_bib112","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/mp.2013.130","article-title":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","volume":"19","author":"Sanacora","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib113","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/npp.2016.224","article-title":"Adjunctive Lanicemine (AZD6765) in patients with major depressive disorder and history of inadequate response to antidepressants: a randomized, placebo-controlled study","volume":"42","author":"Sanacora","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.ajp.2025.104502_bib114","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2215-0366(20)30099-7","article-title":"Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications","volume":"7","author":"Schramm","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"10.1016\/j.ajp.2025.104502_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126804","article-title":"R)-(-)-Ketamine: the promise of a novel treatment for psychiatric and neurological disorders","volume":"25","author":"Shafique","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib116","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ajp.2025.104502_bib117","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2017.03.015","article-title":"Gene expression in blood of children and adolescents: mediation between childhood maltreatment and major depressive disorder","volume":"92","author":"Spindola","year":"2017","journal-title":"J. Psychiatr. Res"},{"issue":"6","key":"10.1016\/j.ajp.2025.104502_bib118","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1017\/S109285291900155X","article-title":"Dextromethorphan\/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity-Addendum","volume":"25","author":"Stahl","year":"2020","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib119","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41386-018-0253-z","article-title":"Correction: dose-related effects of adjunctive ketamine in taiwanese patients with treatment-resistant depression","volume":"44","author":"Su","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.ajp.2025.104502_bib120","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1021\/acschemneuro.1c00371","article-title":"Quercitrin rapidly alleviated depression-like behaviors in lipopolysaccharide-treated mice: the involvement of PI3K\/AKT\/NF-\u03baB signaling suppression and CREB\/BDNF signaling restoration in the hippocampus","volume":"12","author":"Sun","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib121","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cell.2006.03.040","article-title":"Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis","volume":"125","author":"Sutton","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ajp.2025.104502_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109918","article-title":"Convergence of distinct signaling pathways on synaptic scaling to trigger rapid antidepressant action","volume":"37","author":"Suzuki","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib123","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/13543784.2012.638916","article-title":"Investigational NMDA receptor modulators for depression","volume":"21","author":"Szewczyk","year":"2012","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib124","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1684\/mrh.2018.0442","article-title":"The role of magnesium and zinc in depression: similarities and differences","volume":"31","author":"Szewczyk","year":"2018","journal-title":"Magnes. Res"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00406-021-01365-6","article-title":"Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling","volume":"272","author":"Tan","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2025.104502_bib126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2020.03.040","article-title":"Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice","volume":"269","author":"Tan","year":"2020","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2025.104502_bib127","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2018.07.003","article-title":"Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine","volume":"172","author":"Tian","year":"2018","journal-title":"Pharm. Biochem Behav."},{"issue":"ement I","key":"10.1016\/j.ajp.2025.104502_bib128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.22365\/jpsych.2021.046","article-title":"The burden and the challenge of treatment-resistant depression","volume":"32","author":"Touloumis","year":"2021","journal-title":"Psychiatriki"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharm. Rev."},{"issue":"7","key":"10.1016\/j.ajp.2025.104502_bib130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0092-8674(00)81827-9","article-title":"The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory","volume":"87","author":"Tsien","year":"1996","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ajp.2025.104502_bib131","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1460-9568.2006.04787.x","article-title":"Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity","volume":"23","author":"Volbracht","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib132","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers","volume":"57","author":"White","year":"1985","journal-title":"Stud. Volunt. Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.ajp.2025.104502_bib133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib134","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/17512433.2023.2198703","article-title":"Clinical pharmacological innovation in the treatment of depression","volume":"16","author":"Witkin","year":"2023","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"33","key":"10.1016\/j.ajp.2025.104502_bib135","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ajp.2025.104502_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107710","article-title":"Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice","volume":"158","author":"Yamada","year":"2019","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.ajp.2025.104502_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104502_bib138","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2016.03.034","article-title":"Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine","volume":"239","author":"Yang","year":"2016","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.ajp.2025.104502_bib139","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.biopsych.2016.12.020","article-title":"R)-Ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine","volume":"82","author":"Yang","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104502_bib140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2025.104502_bib141","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.ajp.2025.104502_bib142","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41386-023-01577-5","article-title":"Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study","volume":"48","author":"Zaki","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"7604","key":"10.1016\/j.ajp.2025.104502_bib143","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib144","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.ajp.2025.104502_bib145","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"11","key":"10.1016\/j.ajp.2025.104502_bib146","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2025.104502_bib147","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopsych.2012.10.019","article-title":"A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression","volume":"74","author":"Zarate","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104502_bib148","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.ajp.2025.104502_bib149","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2020.01.002","article-title":"Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies","volume":"265","author":"Zheng","year":"2020","journal-title":"J. Affect Disord."},{"issue":"5","key":"10.1016\/j.ajp.2025.104502_bib150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaac.2023.05.031","article-title":"Effect of repeated intravenous esketamine on adolescents with major depressive disorder and suicidal ideation: a randomized active-placebo-controlled trial","volume":"63","author":"Zhou","year":"2024","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"13","key":"10.1016\/j.ajp.2025.104502_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17134710","article-title":"Assessment of ketamine and its enantiomers in an organophosphate-based rat model for features of Gulf War Illness","volume":"17","author":"Zhu","year":"2020","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.ajp.2025.104502_bib152","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2014.10.009","article-title":"Allosteric modulators of NMDA receptors: multiple sites and mechanisms","volume":"20","author":"Zhu","year":"2015","journal-title":"Curr. Opin. Pharm."},{"issue":"12","key":"10.1016\/j.ajp.2025.104502_bib153","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.neuron.2022.03.021","article-title":"Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury","volume":"110","author":"Zong","year":"2022","journal-title":"Neuron"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201825001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201825001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:38:24Z","timestamp":1786091904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201825001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":153,"alternative-id":["S1876201825001455"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104502","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104502"}}